-+ 0.00%
-+ 0.00%
-+ 0.00%

PRELUDE THERAPEUTICS INCORPORATED : JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $12

Reuters·09/17/2026 04:21:44

Please log in to view news